AbbVie Inc. (ABBV) vs Eli Lilly and Company (LLY)
A side-by-side comparison of AbbVie Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs LLY
growth of $100 · dividends reinvested · last 14yABBV +1164.7%LLY +3106.8%LLY compounded faster
ABBV LLY
ABBV vs LLY: by the numbers
- •LLY is the larger company ($1.15T vs $465.51B market cap).
- •LLY trades at the lower trailing earnings multiple (42.54 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 5.79% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 0.54%).
Metrics side by side
Valuation
| Metric | ABBV | LLY |
|---|---|---|
| P/E ratio | 125.98 | 42.54 |
| Forward P/E | N/A | 34.10 |
| P/S ratio | 7.26 | 14.85 |
| P/B ratio | 16.57 | 34.39 |
| PEG ratio | N/A | 0.49 |
| EV / EBITDA | 20.46 | 31.98 |
| FCF yield | 4.58% | 1.27% |
Profitability
| Metric | ABBV | LLY |
|---|---|---|
| Gross margin | 70.68% | 83.51% |
| Operating margin | 27.60% | 45.87% |
| Net margin | 5.79% | 34.98% |
| ROE | 13.23% | 81.01% |
| ROIC | 12.97% | 30.20% |
Dividends
| Metric | ABBV | LLY |
|---|---|---|
| Dividend yield | 2.62% | 0.54% |
| Payout ratio | 284.39% | 28.09% |
Growth (annualized)
| Metric | ABBV | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 23.17% |
| EPS CAGR (5Y) | -2.79% | 28.88% |
| FCF CAGR (5Y) | 3.24% | 19.54% |
| Total return CAGR (5Y) | 21.24% | 38.81% |
Frequently asked
- Which has the lower trailing P/E, ABBV or LLY?
- LLY has the lower trailing P/E: ABBV trades at 125.98 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or LLY?
- Over the past five years, LLY grew revenue faster — ABBV at a 4.59% CAGR versus LLY at 23.17%.
- Does ABBV or LLY pay a bigger dividend?
- ABBV yields 2.62% and LLY yields 0.54% based on trailing dividends and the latest price.
- Is ABBV or LLY more profitable?
- LLY runs the higher net margin — ABBV at 5.79% versus LLY at 34.98%.
- How have ABBV and LLY total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioEli Lilly and P/E ratioAbbVie dividend yieldEli Lilly and dividend yieldAbbVie ROEEli Lilly and ROEAbbVie operating marginEli Lilly and operating marginAbbVie revenue growthEli Lilly and revenue growthAbbVie free cash flowEli Lilly and free cash flow
AbbVie & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.